Galmed Pharmaceuticals Stock Forecast - Price Action Indicator
| GLMD Stock | USD 0.79 0 0.13% |
Galmed Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Galmed Pharmaceuticals stock prices and determine the direction of Galmed Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Galmed Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, the RSI of Galmed Pharmaceuticals' share price is approaching 38. This usually indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Galmed Pharmaceuticals, making its price go up or down. Momentum 38
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.51) | EPS Estimate Current Year (2.31) | EPS Estimate Next Year (0.85) | Wall Street Target Price 12 | EPS Estimate Current Quarter (0.54) |
Using Galmed Pharmaceuticals hype-based prediction, you can estimate the value of Galmed Pharmaceuticals from the perspective of Galmed Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
Galmed Pharmaceuticals after-hype prediction price | USD 0.78 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Galmed Pharmaceuticals to cross-verify your projections. Galmed Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Galmed price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Galmed using various technical indicators. When you analyze Galmed charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| (0.04) | 0.0015 |
| Check Galmed Pharmaceuticals Volatility | Backtest Galmed Pharmaceuticals | Information Ratio |
Galmed Pharmaceuticals Trading Date Momentum
| On January 27 2026 Galmed Pharmaceuticals was traded for 0.79 at the closing time. The top price for the day was 0.79 and the lowest listed price was 0.79 . There was no trading activity during the period 0.0. Lack of trading volume on January 27, 2026 did not cause price change. The overall trading delta against the current closing price is 0.13% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Galmed Pharmaceuticals to competition |
Other Forecasting Options for Galmed Pharmaceuticals
For every potential investor in Galmed, whether a beginner or expert, Galmed Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Galmed Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Galmed. Basic forecasting techniques help filter out the noise by identifying Galmed Pharmaceuticals' price trends.Galmed Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Galmed Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Galmed Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Galmed Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Galmed Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Galmed Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Galmed Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Galmed Pharmaceuticals stock market strength indicators, traders can identify Galmed Pharmaceuticals entry and exit signals to maximize returns.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.79 | |||
| Day Typical Price | 0.79 | |||
| Price Action Indicator | 0.0015 | |||
| Period Momentum Indicator | 0.001 | |||
| Relative Strength Index | 38.7 |
Galmed Pharmaceuticals Risk Indicators
The analysis of Galmed Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Galmed Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting galmed stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.92 | |||
| Standard Deviation | 5.22 | |||
| Variance | 27.24 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Galmed Pharmaceuticals
The number of cover stories for Galmed Pharmaceuticals depends on current market conditions and Galmed Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Galmed Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Galmed Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Galmed Pharmaceuticals Short Properties
Galmed Pharmaceuticals' future price predictability will typically decrease when Galmed Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Galmed Pharmaceuticals often depends not only on the future outlook of the potential Galmed Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Galmed Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 930.8 K | |
| Cash And Short Term Investments | 15.3 M |
Check out Historical Fundamental Analysis of Galmed Pharmaceuticals to cross-verify your projections. For information on how to trade Galmed Stock refer to our How to Trade Galmed Stock guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Galmed Pharmaceuticals. If investors know Galmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Galmed Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Galmed Pharmaceuticals is measured differently than its book value, which is the value of Galmed that is recorded on the company's balance sheet. Investors also form their own opinion of Galmed Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Galmed Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Galmed Pharmaceuticals' market value can be influenced by many factors that don't directly affect Galmed Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Galmed Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Galmed Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Galmed Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.